Business Wire

Xsolla Partners With iBLOXX to Promote Their Web3 Games Globally and Drive Launch of Upcoming Third-person Shooter Title StrayShot

11.12.2024 10:00:00 CET | Business Wire | Press release

Share

iBLOXX Leverages Xsolla’s Monetization, Marketing, And Distribution Tools To Showcase Games Across MENA

Xsolla, a global video game commerce company, announces a new partnership with iBLOXX, a studio specializing in developing next-generation multiplayer games on the blockchain. The alliance was cultivated at the PGC Dubai event in April 2024, underscoring Xsolla’s continuous commitment to fostering long-term growth within the Middle East and Northern Africa region’s rapidly expanding gaming ecosystem.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211854266/en/

null

(Graphic: Xsolla)

This strategic collaboration starts with supporting the launch of their new title, StrayShot. This thrilling third-person shooter game for PC and mobile allows players to step into the boots of a Bounty Hunter, ready to take on rivals in intense matches in several game modes. Players can team up with friends or go solo to fight other players in an epic battle for survival and earn exclusive rewards. This game is unique as it includes Web3 elements, NFTs, and tournaments, all of which Xsolla has solutions to support, particularly when it comes to subscription and virtual currency.

As a pivotal force within the MENA gaming ecosystem, Xsolla continues to leverage its advanced tools and platforms to empower partners and developers. Through this collaboration with iBLOXX, Xsolla is set to elevate the game studio’s reach and performance by providing key monetization, marketing, and distribution capabilities. Xsolla’s payments and monetization technology and expertise will ensure StrayShot gains maximum exposure while optimizing player engagement and revenue generation across multiple channels.

Chris Meredith, SVP EMEA at Xsolla, expressed his enthusiasm about the new partnership, commenting, “It’s great to work with a mature studio in the region with such a long-standing commitment to the growth and development in MENA,” he added. “This partnership will bring their groundbreaking titles and the launch of their newest title, StrayShot, to a wider audience, putting them firmly on the map as a major player in the industry.”

Domenik Maier, CEO of iBLOXX, stated: “We’re thrilled to join forces with Xsolla. Their support will be a game-changer for the upcoming launch of StrayShot, ensuring that it reaches a much larger, more engaged audience!”

The collaboration highlights Xsolla’s unwavering commitment to supporting long-term partnerships that contribute to the sustained growth and innovation of the regional gaming landscape. By partnering with iBLOXX, Xsolla is further enhancing its position in the MENA market, where gaming is experiencing rapid evolution and expansion.

For more information on Xsolla's partnership with iBLOXX to promote Web3 games globally and drive the launch of the upcoming third-person shooter StrayShot, visit xsolla.blog/xipw.

About Xsolla

Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in London, Berlin, Seoul, Beijing, Kuala Lumpur, Raleigh, Tokyo, Montreal, and cities around the world.

For additional information and to learn more, please visit xsolla.com.

About iBLOXX

iBLOXX is a leading innovator in Web3 gaming, leveraging its extensive background in decentralized technologies and quantitative finance to craft robust, player-driven game economies and deeply engaging virtual worlds. By blending cutting-edge blockchain infrastructure with innovative design principles, iBLOXX aims to deliver richer gaming experiences — where players truly own their in-game assets and game worlds evolve in tandem with their communities.

For additional information about their upcoming title StrayShot, please visit StrayShot.game.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241211854266/en/

null

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release

Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe

SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo

NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release

NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding

European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release

European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili

Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye